These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4044192)

  • 1. In vitro testing for the risk of arachnoiditis from myelographic contrast media.
    Cheung HS; Johansen JG; Haughton VM; Nichols TR
    Invest Radiol; 1985 Aug; 20(5):472-5. PubMed ID: 4044192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arachnoiditis from myelography with iopamidol, metrizamide, and iocarmate compared in the animal model.
    Haughton VM; Ho KC
    Invest Radiol; 1980; 15(6 Suppl):S267. PubMed ID: 7203934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of arachnoiditis from experimental nonionic contrast media.
    Haughton VM; Ho KC
    Radiology; 1980 Aug; 136(2):395-7. PubMed ID: 6773100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of blood on arachnoiditis from aqueous myelographic contrast media.
    Haughton VM; Ho KC
    AJR Am J Roentgenol; 1982 Sep; 139(3):569-70. PubMed ID: 6810668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of postmyelographic arachnoiditis.
    Garancis JC; Haughton VM
    Invest Radiol; 1985; 20(1):85-9. PubMed ID: 3980181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental production of arachnoiditis with water-soluble myelographic media.
    Haughton VM; Ho KC; Larson SJ; Unger GF; Correa-Paz F
    Radiology; 1977 Jun; 123(3):681-5. PubMed ID: 404664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arachnoiditis from experimental myelography with aqueous contrast media.
    Haughton VM; Eldevik OP; Ho KC; Larson SJ; Unger GF
    Spine (Phila Pa 1976); 1978 Mar; 3(1):65-9. PubMed ID: 417405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychopathometric demonstration and quantification of mental disturbances following myelography with metrizamide and iopamidol.
    Galle G; Huk W; Arnold K
    Neuroradiology; 1984; 26(3):229-33. PubMed ID: 6738855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal toxicity of iohexol vs. metrizamide. Survey and current state.
    Haughton VM
    Invest Radiol; 1985; 20(1 Suppl):S14-7. PubMed ID: 3918951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arachnoiditis following myelography with water-soluble agents. The role of contrast medium osmolality.
    Haughton VM; Ho KC; Unger GF
    Radiology; 1977 Dec; 125(3):731-3. PubMed ID: 412226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late meningeal effects of myelographic contrast media with special reference to metrizamide.
    Hansen EB; Fahrenkrug A; Praestholm J
    Br J Radiol; 1978 May; 51(605):321-7. PubMed ID: 638401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative experimental study of central nervous system tolerability of the administration of iopamidol, metrizamide, ioxitalamate, ioxaglate and iocarmate].
    Cahn J; Borzeix MG; Cahn R
    Ann Radiol (Paris); 1983 Dec; 26(8 Pt 2):774-8. PubMed ID: 6670839
    [No Abstract]   [Full Text] [Related]  

  • 13. Elimination of aqueous myelographic contrast media from the subarachnoid space.
    Eldevik OP; Haughton VM; Sasse EA
    Invest Radiol; 1980; 15(6 Suppl):S260-3. PubMed ID: 7203932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arachnoid response to contrast media: a comparison of iophendylate and metrizamide in experimental animals.
    Haughton VM; Ho KC
    Radiology; 1982 Jun; 143(3):699-702. PubMed ID: 6805038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iotrol, a new water-soluble non-ionic dimeric contrast medium for intrathecal use.
    Hammer B; Deisenhammer E
    Neuroradiology; 1985; 27(4):337-41. PubMed ID: 3900800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of arachnoiditis produced by meglumine iocarmate and metrizamide myelography in an animal model.
    Haughton VM; Ho KC; Larson SJ; Unger GF; Correa-Paz F
    AJR Am J Roentgenol; 1978 Jul; 131(1):129-32. PubMed ID: 97964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hazards of myelography.
    Peterson HO
    Radiology; 1975 Apr; 115(1):237-9. PubMed ID: 164045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iopamidol, a new non-ionic hydrosoluble contrast medium for neuroradiology.
    Hammer B; Lackner W
    Neuroradiology; 1980 Apr; 19(3):119-21. PubMed ID: 6991972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of myelographic contrast-medium tolerance with psychometric testing.
    Hammeke TA; Grogan JP; Haughton VM; Pfeiffer MM; Harrington GJ; Sudilovsky A
    AJNR Am J Neuroradiol; 1985; 6(3):343-8. PubMed ID: 3923791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adhesive arachnoiditis following lumbar radiculography with water-soluble contrast agents. A clinical report with special reference to metrizamide.
    Skalpe IO
    Radiology; 1976 Dec; 121(3 Pt. 1):647-51. PubMed ID: 185649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.